|8:45am||Welcome, objectives, process|
Ron Weiss, MIT
|9:00am||Mammalian synthetic biology tools|
- Martin Fussenegger, ETH: "Prosthetic networks: A new treatment strategy for metabolic disorders"
- Pam Silver, Harvard: "Designing systems to interrogate and re-program cell state"
- Philip Gregory, Sangamo BioSciences: "Genome editing with zinc finger nucleases"
|11:00am||Mammalian synthetic biology tools|
- Ron Weiss, MIT: "From parts to modules to therapeutic systems using mammalian synthetic biology"
- Philip Dormitzer, Novartis: "Synthetic vaccines: Synthetic biology approaches the clinic"
|1:00pm||Technology-focused breakout sessions |
- Advances in DNA assembly and delivery
- Advances in transcriptional regulation
- Advances in sensors and actuators
- Advances in non-transcriptional regulation
- Doug Melton, Harvard: "Multiple routes to investigate type 1 diabetes"
- David Schaffer, Berkeley: “Molecular engineering and evolution of new viruses for mammalian gene delivery”
- Harvey Lodish, MIT: "Genetically and chemically modified red blood cells as novel therapeutics, immunomodulatory agents, and imaging probes"
- Tyler Jacks, MIT: "Modeling cancer in the mouse"
|4:30pm||Disease and scientific inquiry focused-breakout sessions|
- Opportunities and challenges in cancer
- Opportunities and challenges in stem cells and tissue engineering
- Opportunities and challenges in vaccination and infectious disease
- Opportunities and challenges in diabetes and metabolic diseases
- Opportunities and challenges in neurosciences
- Opportunities and challenges in scientific inquiry
- Opportunities and challenges in drug screening
|6:00pm||Poster session and buffet dinner|
|8:00pm||End of day's activities|